ASGCT 2025 x KACTUS
KACTUS is excited to announce our participation in the American Society of Gene and Cell Therapy ASGCT 2025 Annual Meeting—the premier global event for gene and cell therapy advancement. Taking place from May 13–16, 2025, in New Orleans, Louisiana, ASGCT brings together leading scientists, clinicians, and industry experts to share the latest breakthroughs in genetic medicines. With five days of scientific sessions, poster forums, and networking, it’s the definitive platform for shaping the future of gene and cell-based therapeutics.
What is the American Society of Gene and Cell Therapy ?
The American Society of Gene and Cell Therapy (ASGCT) Annual Meeting is the leading global event dedicated to advancing genetic and cellular medicines. It brings together pioneering scientists, clinicians, regulatory experts, and industry leaders to explore breakthroughs in gene editing, vector engineering, cell therapy, and translational research. Renowned for its scientific rigor and interdisciplinary collaboration, ASGCT serves as a cornerstone for innovation in next-generation therapeutics.
Event Overview
Venue: Ernest N. Morial Convention Center, 900 Convention Center Blvd, New Orleans, LA 70130
Dates: May 13th to 16th
-
Conference Day 2: Tuesday, May 13, 2025 – 8:00 AM to 7:00 PM
-
Conference Day 3: Wednesday, May 14, 2025 – 8:00 AM to 5:30 PM
-
Conference Day 4: Thursday, May 15, 2025 – 8:00 AM to 5:30 PM
-
Conference Day 5: Friday, May 16, 2025 – 8:00 AM to 5:30 PM
Booth #1813
🎤 Featured Talk – MaxNuclease™
📅 Date: Thursday, May 14
⏰ Time: 4:00 PM
📍Tools & Technology Forum, Session Title: Revolutionize Viral Vector Manufacturing with Cost-Effective S. marcescens Nuclease: MaxNuclease™
📌Posters
🧬 High-Performing GMP CRISPR Cas9 Nuclease for Cell and Gene Therapy
🗓️ May 14, 2025 | 🕠 5:30 PM – 7:00 PM | Poster #1349
🧫 Tailored AAV Solutions: AAV ELISA Kits and Customized Variant Kit Development
🗓️ May 14, 2025 | 🕠 5:30 PM – 7:00 PM | Poster #1490
🧪 The Second-Generation High-Fidelity Cytosine Base Editor AccuBase™ Can Proficiently Modify Multiple Genes Within a Human Primary T Cell While Minimizing Off-Target Effects
🗓️ May 15, 2025 | 🕠 5:30 PM – 7:00 PM | Poster #1595
Event Schedule
ASGCT’s Annual Meeting is where science meets momentum in gene and cell therapy. From data-driven sessions to dynamic poster presentations and meaningful networking, the event offers a comprehensive view of the progress driving the field forward. Check out the full program to see how each day contributes to the future of genetic medicine.
Tuesday, May 13
-
Workshops (Separate Registration Required) from 8:00 AM to 12:00 PM
-
Oral Abstract Sessions and Scientific Symposium from 1:30 PM to 3:15 PM
-
General Session – Awards Symposium from 3:45 PM to 5:30 PM
-
Welcome Reception and Poster Reception from 5:30 PM to 7:30 PM
Wednesday, May 14
-
Scientific Symposia and Oral Abstracts from 8:00 AM to 9:45 AM
-
General Session – Presidential Symposium from 10:15 AM to 12:00 PM
-
Poster Talks and Networking from 12:15 PM to 1:00 PM
-
Oral Abstracts and Fireside Chats from 1:30 PM to 3:15 PM
-
Networking, Poster Talks, and Meetups from 3:15 PM to 4:15 PM
-
Oral Abstracts and Fireside Chats from 4:15 PM to 5:30 PM
-
Poster Reception from 5:30 PM to 7:00 PM
Thursday, May 15
-
Scientific Symposia and Oral Abstracts from 8:00 AM to 9:45 AM
-
General Session – George Stamatoyannopoulos Memorial Lecture from 10:15 AM to 12:00 PM
-
Poster Talks and Networking from 12:15 PM to 1:00 PM
-
Oral Abstracts and Fireside Chats from 1:30 PM to 3:15 PM
-
Oral Abstracts and Fireside Chats from 3:45 PM to 5:30 PM
-
Poster Reception from 5:30 PM to 7:00 PM
Friday, May 16
-
Scientific Symposia and Oral Abstract Sessions from 8:00 AM to 9:45 AM
-
General Session – Founders, Mendell, and Catalyst Award Symposium from 10:15 AM to 12:00 PM
-
Oral Abstract Sessions from 1:30 PM to 3:15 PM
-
General Session – Gene Therapy Trials and In-Vivo Gene Therapy Modification from 3:45 PM to 5:30 PM
-
Closing Night Reception (Separate Purchase Required) from 7:00 PM to 10:00 PM at Mardi Gras World
About KACTUS
KACTUS specializes in the development and production of high-quality, bioactive recombinant proteins and enzymes that support innovation across antibody drug discovery, immunotherapy, gene therapy, and mRNA therapeutics. With a catalog of over 2,500 recombinant proteins spanning diverse targets, species, tags, and formats, we are committed to meeting the evolving needs of scientists in translational research. Our focus on rigorous quality control and reliable supply ensures the consistency and performance that today’s therapeutic development demands.
Featured Products
Explore more
Popular posts
